STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Vitrolife (STO:VITR): The results of the HELP (Human ex vivo Lung Perfusion) study on STEEN Solution™ show that transplantation with ex vivo evaluated lungs was at least as good as in the control group. This conclusion was presented during the ISHLT congress in Chicago in April.
